Menu
  • The 5th annual E-Cigarette Summit will take place on Friday 17th November at The Royal Society, London
  • Registration for the E-Cigarette Summit 2017 is now open

Welcome to The E-Cigarette Summit 2017

The 5th annual E-Cigarette Summit will take place at the Royal Society in London on Friday 17th November 2017.

Since the inaugural meeting in November 2013, The E-Cigarette Summit has been at the forefront of taking forward the scientific and public health debate around e-cigarettes and broader harm reduction debates. The Summit has established itself as a neutral environment for scientists, policy makers, medical and public health professionals and stakeholders to come together and look at the latest scientific research and evidence on e-cigarettes and debate their impact. In 2013, the conversation was UK centric as the public health and policy communities sought to find an appropriate regulatory system for e-cigarettes that would reflect the opportunities for smokers without ignoring potential harms.  In the intervening years, the UK has emerged as an active proponent for tobacco harm reduction alongside stringent tobacco control measures and now five years on the Summit welcomes  scientists, public health professionals and policy makers from around the world who are looking to establish their own regulatory framework in the face of new nicotine products.

Alongside the latest evidence on the safety of e-cigarettes for users and bystanders, The E-Cigarette Summit will continue to address broader debates including evidence on “gateway” for youth and non-smokers, advertising and marketing, use in public places and the conflicts arising from the tobacco industry’s dual corporate ownership of tobacco harm reduction products and cigarettes.  The role that e-cigarettes could play in ending or extending the smoking epidemic will remain one of the most fiercely fought debates in public health history.

For governments and policy makers/advisors, the weight of making the right decision cannot be underestimated.  From outright bans, advertising restrictions to higher taxation; the way that each country introduces, interprets and implements legislation, including consumer and medical licensing routes, will have far reaching consequences.  Setting the regulatory bar at the correct level, will be vital to harnessing the opportunities that e-cigarettes and reduced harm nicotine products could offer while remaining responsive to a tobacco control manifesto to reduce smoking related harm.

What questions will be explored?

The E-Cigarette Summit will include high level briefings from experts and encourages interaction through panel debates and open floor discussions.  Questions will be explored in a balanced and objective environment allowing attendees to build their knowledge and share their viewpoints. The E-Cigarette Summit will explore the latest research and evidence on the following areas:

  • The Continuum of Harm Reduction and different policy/regulatory approaches
  • E-Cigarette safety and research
  • Nicotine health impacts including addiction
  • Dual use – how concerned should we be
  • Heat not Burn and E-cigarettes – similarities and differences
  • Advertising restrictions – how to reach smokers and protect youth
  • Medicinal Licensing – is this a viable route and where are the products
  • What does the evidence say about gateway
  • Are there health risks through second hand vapour for non-users
  • If e-cigarettes are so good, why aren’t all smokers using them

Who Should Attend?

In particular, this event will be relevant to:

  • Regulators and policy advisors
  • Scientific/research community
  • Smoking cessation practitioners/services
  • Health providers, health charities and health campaigners
  • Local Authorities and Environmental Health
  • Public health professionals and academics
  • Medical and health professionals
  • e-cigarette industry and broader stakeholders groups